Shares of DocuSign, Inc. (NASDAQ:DOCU – Get Free Report) have been assigned a consensus recommendation of “Hold” from the sixteen ratings firms that are covering the company, MarketBeat Ratings reports. One analyst has rated the stock with a sell recommendation, eleven have given a hold recommendation and four have assigned a buy recommendation to the company. The average twelve-month price objective among brokerages that have covered the stock in the last year is $89.15.
DOCU has been the topic of several recent research reports. Wedbush dropped their target price on shares of DocuSign from $100.00 to $85.00 and set a “neutral” rating on the stock in a report on Friday. UBS Group dropped their target price on shares of DocuSign from $85.00 to $80.00 and set a “neutral” rating on the stock in a report on Friday. William Blair restated an “outperform” rating on shares of DocuSign in a report on Monday, April 21st. Needham & Company LLC restated a “hold” rating on shares of DocuSign in a report on Friday. Finally, Morgan Stanley lowered their price target on shares of DocuSign from $92.00 to $86.00 and set an “equal weight” rating on the stock in a report on Friday.
Check Out Our Latest Research Report on DOCU
Insider Activity at DocuSign
Hedge Funds Weigh In On DocuSign
Institutional investors have recently bought and sold shares of the business. Banque Transatlantique SA purchased a new position in DocuSign during the 1st quarter worth approximately $26,000. Hemington Wealth Management raised its position in DocuSign by 318.1% during the 1st quarter. Hemington Wealth Management now owns 347 shares of the company’s stock worth $28,000 after buying an additional 264 shares during the last quarter. Kestra Investment Management LLC purchased a new position in DocuSign during the 4th quarter worth approximately $30,000. Golden State Wealth Management LLC raised its position in DocuSign by 519.4% during the 1st quarter. Golden State Wealth Management LLC now owns 384 shares of the company’s stock worth $31,000 after buying an additional 322 shares during the last quarter. Finally, Summit Securities Group LLC purchased a new position in DocuSign during the 1st quarter worth approximately $34,000. 77.64% of the stock is owned by hedge funds and other institutional investors.
DocuSign Price Performance
Shares of DocuSign stock opened at $75.28 on Monday. DocuSign has a 1 year low of $48.80 and a 1 year high of $107.86. The firm’s 50-day moving average is $82.08 and its two-hundred day moving average is $86.32. The stock has a market cap of $15.24 billion, a price-to-earnings ratio of 15.52, a PEG ratio of 6.94 and a beta of 1.14.
DocuSign (NASDAQ:DOCU – Get Free Report) last issued its earnings results on Thursday, June 5th. The company reported $0.90 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.81 by $0.09. DocuSign had a net margin of 34.73% and a return on equity of 14.90%. The company had revenue of $763.65 million for the quarter, compared to analysts’ expectations of $748.79 million. During the same period in the prior year, the business earned $0.82 EPS. The firm’s quarterly revenue was up 7.6% on a year-over-year basis. On average, equities analysts expect that DocuSign will post 1.17 earnings per share for the current year.
DocuSign declared that its Board of Directors has approved a stock buyback plan on Thursday, June 5th that authorizes the company to repurchase $1.00 billion in shares. This repurchase authorization authorizes the company to repurchase up to 6.6% of its shares through open market purchases. Shares repurchase plans are often a sign that the company’s leadership believes its stock is undervalued.
DocuSign Company Profile
DocuSign, Inc provides electronic signature solution in the United States and internationally. The company provides e-signature solution that enables sending and signing of agreements on various devices; Contract Lifecycle Management (CLM), which automates workflows across the entire agreement process; Document Generation streamlines the process of generating new, custom agreements; and Gen for Salesforce, which allows sales representatives to automatically generate agreements with a few clicks from within Salesforce.
Featured Stories
- Five stocks we like better than DocuSign
- Ride Out The Recession With These Dividend KingsĀ
- Five Below Pops on Strong Earnings, But Rally May Stall
- 3 Grocery Stocks That Can Help Take a Bite Out of Inflation
- Intel’s Dual Gamble: AI Innovation Now, Foundry Fortunes Later?
- Which Wall Street Analysts are the Most Accurate?
- X: 1 Reason to Bet on U.S. Steel, and 1 Reason to Hold Back
Receive News & Ratings for DocuSign Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DocuSign and related companies with MarketBeat.com's FREE daily email newsletter.